Systemic Release and Protective Role of IL-10 in Staphylococcal Enterotoxin B-induced Shock in Mice
Overview
Authors
Affiliations
Staphylococcal enterotoxin B (SEB) is a bacterial superantigen that induces the production of several pro-inflammatory cytokines, leading to a self-limited shock. In the present study, we show that SEB also triggers the systemic release of IL-10, an anti-inflammatory and immunosuppressive cytokine. Serum IL-10 was undetectable (< 1000 pg/ml) in control BALB/c mice and rose to 8500 +/- 2850 pg/ml (mean +/- SEM) 4 h after injection of 100 micrograms SEB. Cell depletion experiments and analysis of IL-10 mRNA expression indicated that CD4+ cells played a major role in SEB-induced IL-10 production. Pretreatment of mice with neutralizing anti-IL-10 mAb before SEB challenge did not modify the release of TNF but led to increased and sustained IL-2 and IFN-gamma serum levels. Furthermore, although no lethality occurred in mice injected with SEB and control mAb, injection of anti-IL-10 mAb before SEB resulted in a 30% lethality (p < 0.05). This lethality was completely prevented by anti-IFN-gamma mAb injection, indicating that IFN-gamma plays a crucial role in the increased toxicity of SEB in anti-IL-10 mAb-injected mice. We conclude that SEB induces the production of IL-10 by CD4+ cells in vivo and that endogenous IL-10 plays an important immunoregulatory role in this model by down-regulating IL-2 and IFN-gamma production.
Superantigen Recognition and Interactions: Functions, Mechanisms and Applications.
Deacy A, Gan S, Derrick J Front Immunol. 2021; 12:731845.
PMID: 34616400 PMC: 8488440. DOI: 10.3389/fimmu.2021.731845.
Antimicrobial responses of peripheral and central nervous system glia against Staphylococcus aureus.
Choudhury I, Chacko A, Delbaz A, Chen M, Basu S, St John J Sci Rep. 2021; 11(1):10722.
PMID: 34021227 PMC: 8140078. DOI: 10.1038/s41598-021-90252-0.
Long G, Graham A Evol Appl. 2015; 4(2):278-91.
PMID: 25567973 PMC: 3352548. DOI: 10.1111/j.1752-4571.2010.00178.x.
B-cell-mediated strategies to fight chronic allograft rejection.
Dalloul A Front Immunol. 2014; 4:444.
PMID: 24381571 PMC: 3865384. DOI: 10.3389/fimmu.2013.00444.
Gil C, Solano C, Burgui S, Latasa C, Garcia B, Toledo-Arana A Infect Immun. 2013; 82(3):1017-29.
PMID: 24343648 PMC: 3957983. DOI: 10.1128/IAI.01419-13.